Application of Artificial Intelligence (AI) System in Opportunistic Screening and Diagnostic Population in a Middle-income Nation
- PMID: 38415464
- DOI: 10.2174/0115734056280191231207052903
Application of Artificial Intelligence (AI) System in Opportunistic Screening and Diagnostic Population in a Middle-income Nation
Abstract
Objective: This study evaluates the effectiveness of artificial intelligence (AI) in mammography in a diverse population from a middle-income nation and compares it to traditional methods.
Methods: A retrospective study was conducted on 543 mammograms of 467 Malays, 48 Chinese, and 28 Indians in a middle-income nation. Three breast radiologists interpreted the examinations independently in two reading sessions (with and without AI support). Breast density and BI-RADS categories were assessed, comparing the accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) results.
Results: Of 543 mammograms, 69.2% had lesions detected. Biopsies were performed on 25%(n=136), with 66(48.5%) benign and 70(51.5%) malignant. Substantial agreement in density assessment between the radiologist and AI software (κ =0.606, p < 0.001) and the BI-RADS category with and without AI (κ =0.74, p < 0.001). The performance of the AI software was comparable to the traditional methods. The sensitivity, specificity, PPV, and NPV or radiologists alone, radiologist + AI, and AI alone were 81.9%,90.4%,56.0%, and 97.1%; 81.0%, 93.1%,55.5%, and 97.0%; and 90.0%,76.5%,36.2%, and 98.1%, respectively. AI software enhances the accuracy of lesion diagnosis and reduces unnecessary biopsies, particularly for BI-RADS 4 lesions. The AI software results for synthetic were almost similar to the original 2D mammography, with AUC of 0.925 and 0.871, respectively.
Conclusion: AI software may assist in the accurate diagnosis of breast lesions, enhancing the efficiency of breast lesion diagnosis in a mixed population of opportunistic screening and diagnostic patients.
Key messages: • The use of artificial intelligence (AI) in mammography for population-based breast cancer screening has been validated in high-income nations, with reported improved diagnostic performance. Our study evaluated the usage of an AI tool in an opportunistic screening setting in a multi-ethnic and middle-income nation. • The application of AI in mammography enhances diagnostic accuracy, potentially leading to reduced unnecessary biopsies. • AI integration into the workflow did not disrupt the performance of trained breast radiologists, as there is a substantial inter-reader agreement for BI-RADS category assessment and breast density.
Keywords: artificial intelligence; breast cancer; density; mammography; multi-ethnic; screening.
Similar articles
-
Influence of AI Decision Support on Radiologists' Performance and Visual Search in Screening Mammography.Radiology. 2025 Jul;316(1):e243688. doi: 10.1148/radiol.243688. Radiology. 2025. PMID: 40626877
-
Inter-reader agreement of the BI-RADS CEM lexicon.Eur Radiol. 2025 May;35(5):2378-2386. doi: 10.1007/s00330-024-11176-7. Epub 2024 Nov 6. Eur Radiol. 2025. PMID: 39505735 Free PMC article.
-
Application Value of Deep Learning-Based AI Model in the Classification of Breast Nodules.Br J Hosp Med (Lond). 2025 Jun 25;86(6):1-19. doi: 10.12968/hmed.2025.0078. Epub 2025 Jun 15. Br J Hosp Med (Lond). 2025. PMID: 40554435
-
Artificial intelligence for diagnosing exudative age-related macular degeneration.Cochrane Database Syst Rev. 2024 Oct 17;10(10):CD015522. doi: 10.1002/14651858.CD015522.pub2. Cochrane Database Syst Rev. 2024. PMID: 39417312
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
Cited by
-
Artificial intelligence utilization in cancer screening program across ASEAN: a scoping review.BMC Cancer. 2025 Apr 15;25(1):703. doi: 10.1186/s12885-025-14026-x. BMC Cancer. 2025. PMID: 40234807 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical